GoHealth (GOCO) Reports Q3 Loss, Tops Revenue Estimates

Core Viewpoint - GoHealth reported a quarterly loss of $3.73 per share, which was worse than the Zacks Consensus Estimate of a loss of $3.19, and a significant increase from a loss of $2.61 per share a year ago, indicating ongoing financial challenges for the company [1] Financial Performance - GoHealth's revenues for the quarter ended September 2024 were $118.29 million, exceeding the Zacks Consensus Estimate by 11.67%, but down from $132.04 million in the same quarter last year [2] - Over the last four quarters, GoHealth has surpassed consensus EPS estimates only once [2] Stock Performance - GoHealth shares have declined approximately 4.4% since the beginning of the year, contrasting with the S&P 500's gain of 24.3% [3] Future Outlook - The company's earnings outlook will be crucial for its stock performance, with current consensus EPS estimates at $1.50 for the upcoming quarter and -$5.35 for the current fiscal year [4][7] - The estimate revisions trend for GoHealth is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6] Industry Context - The Insurance - Life Insurance industry, to which GoHealth belongs, is currently ranked in the top 20% of over 250 Zacks industries, indicating a favorable industry outlook that could positively influence GoHealth's performance [8]